Personalis Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Personalis Stock Summary

Personalis competes with Twist Bioscience, Natera, Guardant Health, Castle Biosciences, and Sera Prognostics. Personalis, Inc. operates as a cancer genomics company worldwide. Personalis, Inc. was incorporated in 2011 and is headquartered in Menlo Park, California. Personalis operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 325 people.

Personalis Key Financial Ratios

Personalis Key Balance Sheet Accounts

Personalis Key Income Statement Accounts

Personalis Key Cash Accounts

Personalis Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Personalis's current stock value. Our valuation model uses many indicators to compare Personalis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Personalis competition to find correlations between indicators driving Personalis's intrinsic value. More Info.Personalis is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Personalis' Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Personalis by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Personalis Systematic Risk

Today, most investors in Personalis Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Personalis' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Personalis growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Personalis help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Personalis. We use our internally-developed statistical techniques to arrive at the intrinsic value of Personalis based on widely used predictive technical indicators. In general, we focus on analyzing Personalis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Personalis's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Personalis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Personalis Stock please use our How to buy in Personalis Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Personalis. If investors know Personalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Personalis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Personalis is measured differently than its book value, which is the value of Personalis that is recorded on the company's balance sheet. Investors also form their own opinion of Personalis' value that differs from its market value or its book value, called intrinsic value, which is Personalis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Personalis' market value can be influenced by many factors that don't directly affect Personalis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Personalis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Personalis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Personalis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.